Mirum Pharmaceuticals 1 article

From a biotechnology perspective, Mirum Pharmaceuticals is a biopharmaceutical company shaped by ileal bile acid transporter inhibition and IBAT inhibitor therapeutics. Mirum Pharmaceuticals combines enterohepatic bile acid circulation modulation, Alagille syndrome therapeutics and oral small molecule liver therapeutics, giving Mirum Pharmaceuticals an explicit target or pathway context. This framing preserves Mirum Pharmaceuticals as the company entity, with cholestatic liver disease contributing context without collapsing products, targets and modalities together.